{
    "clinical_study": {
        "@rank": "95917", 
        "arm_group": {
            "arm_group_label": "Experimental", 
            "arm_group_type": "Experimental", 
            "description": "Device Implantation"
        }, 
        "brief_summary": {
            "textblock": "Current treatment options for bilateral profoundly deaf children, diagnosed with inner ear\n      anatomical abnormalities, are limited and, in the case of absent cochleas, non-existent. An\n      auditory brainstem implant (ABI) places an electrode close to the auditory nucleus in the\n      brainstem. Children aged 2 - 5 who are not candidates for a cochlear implant, or who did not\n      demonstrate benefit from a cochlear implant, will be implanted with an ABI and followed for\n      1 year for safety and a total of 3 years for preliminary efficacy. This is a feasibility\n      study to determine the safety of the ABI."
        }, 
        "brief_title": "A Safety Study of the Auditory Brainstem Implant for Pediatric Profoundly Deaf Patients", 
        "condition": [
            "Profound Bilateral Deafness Due to", 
            "Bilateral Cochlear Aplasia", 
            "Bilateral Cochlear Nerve Deficiency", 
            "Bilateral Cochlear Ossification Secondary to Meningitis"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Deafness", 
                "Hearing Loss", 
                "Meningitis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Bilateral profound deafness due to cochlear aplasia, cochlear nerve deficiency, or\n             ossification secondary to meningitis\n\n          -  If previously received a cochlear implant, must demonstrate lack of benefit from that\n             device\n\n        Exclusion Criteria:\n\n          -  Medical contraindication to craniotomy/intracranial surgery\n\n          -  Severe cognitive or developmental delays"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "6 Years", 
            "minimum_age": "2 Years"
        }, 
        "firstreceived_date": "March 19, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02102256", 
            "org_study_id": "KSOM-ABI 001"
        }, 
        "intervention": {
            "arm_group_label": "Experimental", 
            "intervention_name": "Auditory Brainstem Implant", 
            "intervention_type": "Device", 
            "other_name": "Cochlear Corporation Nucleus 24"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "deafness", 
            "congenital", 
            "pediatric", 
            "device"
        ], 
        "lastchanged_date": "April 11, 2014", 
        "location": [
            {
                "contact": {
                    "email": "amy.martinez@med.usc.edu", 
                    "last_name": "Amy Martinez, MS", 
                    "phone": "213-764-2807"
                }, 
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90008"
                    }, 
                    "name": "Keck School of Medicine of USC"
                }, 
                "investigator": {
                    "last_name": "Laurie Eisenberg, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "Children's Hospital Los Angeles"
                }, 
                "status": "Active, not recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Feasibility Study of the Placement, Use, and Safety of the Nucleus 24 Auditory Brainstem Implant in Non-Neurofibromatosis Type 2 (NF2) Pediatric Patients", 
        "overall_contact": {
            "email": "amy.martinez@med.usc.edu", 
            "last_name": "Amy Martinez, MS", 
            "phone": "213-764-2807"
        }, 
        "overall_contact_backup": {
            "email": "laurie.eisenberg@med.usc.edu", 
            "last_name": "Laurie Eisenberg, PhD", 
            "phone": "213-764-2826"
        }, 
        "overall_official": [
            {
                "affiliation": "Keck School of Medicine of USC", 
                "last_name": "Laurie S. Eisenberg, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Huntington Medical Research Institute", 
                "last_name": "Eric Wilkinson, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "February 2019", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Serious adverse event (count) per subject.  Count of expected serious adverse events per subject.", 
            "measure": "Primary endpoint", 
            "safety_issue": "Yes", 
            "time_frame": "12-months post-device activation"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02102256"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Southern California", 
            "investigator_full_name": "Laurie Eisenberg", 
            "investigator_title": "Professor of Research Otolaryngology", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Access to sound at a level (dB) and with the frequency range (500-4000Hz), known to be associated with speech.", 
                "measure": "Secondary endpoint: Preliminary efficacy", 
                "safety_issue": "No", 
                "time_frame": "3 years post-device activation"
            }, 
            {
                "description": "Unexpected adverse events (count).", 
                "measure": "Unexpected Serious Adverse Events", 
                "safety_issue": "Yes", 
                "time_frame": "12-months post-activation"
            }
        ], 
        "source": "University of Southern California", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Keck School of Medicine of USC", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Children's Hospital Los Angeles", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Huntington Medical Research Institutes", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Laurie Eisenberg", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}